Barlow Wealth Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.08M Buy
7,590
+100
+1% +$13.8K 0.11% 57
2026
Q2
$944K Hold
7,490
– – 0.1% 64
2026
Q1
$892K Sell
7,490
-50
-0.7% -$5.77K 0.1% 62
2025
Q4
$833K Sell
7,540
-85
-1% -$7.98K 0.09% 65
2025
Q3
$668K Sell
7,625
-982
-11% -$80.9K 0.07% 72
2025
Q2
$709K Hold
8,607
– – 0.08% 66
2025
Q1
$712K Sell
8,607
-800
-9% -$74.7K 0.09% 67
2024
Q4
$942K Sell
9,407
-2,509
-21% -$259K 0.12% 59
2024
Q3
$1.29M Sell
11,916
-200
-2% -$23.8K 0.17% 58
2024
Q2
$1.53M Buy
12,116
+21
+0.2% +$2.7K 0.21% 56
2024
Q1
$1.52M Sell
12,095
-25
-0.2% -$3.08K 0.21% 60
2023
Q4
$1.32M Buy
+12,120
New +$1.26M 0.19% 60

Other funds holding MRK

Barlow Wealth Partners's MRK Position: Q3 2026 in Review

Barlow Wealth Partners increased its Merck (MRK) stake by 1.3% in Q3 2026, buying an estimated $13.8K and bringing the position to 7,590 shares worth $1.08M. The position accounts for 0.11% of the portfolio, ranked #57.

Barlow Wealth Partners first reported a position in MRK in Q4 2023 and has held it in 12 quarters since. The position peaked at $1.53M in Q2 2024. 3,520 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Barlow Wealth Partners held 7,590 shares of Merck worth $1.08M as of Q3 2026.
  • Barlow Wealth Partners bought 100 Merck shares in Q3 2026, an estimated $13.8K.
  • Merck made up 0.11% of Barlow Wealth Partners's portfolio in Q3 2026, its #57 holding.
  • Barlow Wealth Partners first reported a position in Merck in Q4 2023 and has held it in 12 quarters since.
  • Barlow Wealth Partners's Merck position peaked at $1.53M in Q2 2024.
  • 3,520 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Barlow Wealth Partners's 13F filing for Q3 2026, filed 15 Oct 2026.